Mirae Asset Global Investments’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.9K	Buy	2,643 +181	+7%	+$3.2K	﹤0.01%	1322
2025 Q4	$46.1K	Buy	2,462 +515	+26%	+$8.54K	﹤0.01%	1408
2025 Q3	$28.4K	Buy	1,947 +15	+0.8%	+$190	﹤0.01%	1444
2025 Q2	$21.3K	Buy	1,932 +287	+17%	+$2.79K	﹤0.01%	1394
2025 Q1	$15.2K	Buy	1,645 +6	+0.4%	+$56	﹤0.01%	1418
2024 Q4	$15.7K	Sell	1,639 -130	-7%	-$1.18K	﹤0.01%	1452
2024 Q3	$14.3K	Buy	1,769 +317	+22%	+$2.75K	﹤0.01%	1474
2024 Q2	$12.1K	Sell	1,452 -51,424	-97%	-$464K	﹤0.01%	1442
2024 Q1	$557K	Buy	52,876 +7,509	+17%	+$69.6K	﹤0.01%	1846
2023 Q4	$510K	Buy	45,367 +835	+2%	+$8.4K	﹤0.01%	1962
2023 Q3	$384K	Buy	44,532 +1,993	+5%	+$19.2K	﹤0.01%	2014
2023 Q2	$440K	Sell	42,539 -10,521	-20%	-$116K	﹤0.01%	2002
2023 Q1	$576K	Buy	53,060 +6,949	+15%	+$73.5K	﹤0.01%	1854
2022 Q4	$517K	Buy	46,111 +4,760	+12%	+$50K	﹤0.01%	1873
2022 Q3	$419K	Buy	41,351 +6,557	+19%	+$61.4K	﹤0.01%	1982
2022 Q2	$315K	Buy	+34,794	New	+$321K	﹤0.01%	1963
2022 Q1	–	Sell	-10,022	Closed	-$110K	–	1636
2021 Q4	$110K	Buy	+10,022	New	+$87.3K	﹤0.01%	1545